Virtus Lifesci Biotech Etf Profile
BBC Etf | USD 29.13 0.17 0.59% |
Performance10 of 100
| Odds Of DistressLess than 9
|
Virtus LifeSci is trading at 29.13 as of the 28th of March 2024, a 0.59 percent up since the beginning of the trading day. The etf's open price was 28.96. Virtus LifeSci has less than a 9 % chance of experiencing financial distress in the next few years and had a ok performance during the last 90 days. Equity ratings for Virtus LifeSci Biotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
Under normal market conditions, the fund will invest not less than 80 percent of its assets in component securities of the index. Virtus Lifesci is traded on NYSEARCA Exchange in the United States. More on Virtus LifeSci Biotech
Moving together with Virtus Etf
0.9 | XLV | Health Care Select | PairCorr |
0.91 | VHT | Vanguard Health Care | PairCorr |
0.92 | XBI | SPDR SP Biotech Sell-off Trend | PairCorr |
0.86 | IHI | IShares US Medical | PairCorr |
0.89 | IXJ | IShares Global Healthcare | PairCorr |
0.9 | IYH | IShares US Healthcare | PairCorr |
Moving against Virtus Etf
0.86 | BITI | ProShares Trust - | PairCorr |
0.43 | GREI | Goldman Sachs Future | PairCorr |
Virtus Etf Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Virtus LifeSci's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Virtus LifeSci or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Thematic Ideas | (View all Themes) |
Business Concentration | Sector ETFs, Health Care ETFs, Health, Virtus (View all Sectors) |
Issuer | Virtus |
Inception Date | 2014-12-16 |
Benchmark | LifeSci Biotechnology Clinical Trials Index |
Entity Type | Regulated Investment Company |
Asset Under Management | 11.31 Million |
Average Trading Valume | 5,666.9 |
Asset Type | Equity |
Category | Sector |
Focus | Health Care |
Market Concentration | Developed Markets |
Region | North America |
Administrator | Virtus ETF Solutions, LLC |
Advisor | Virtus ETF Advisers LLC |
Custodian | The Bank of New York Mellon Corporation |
Distributor | ETF Distributors LLC |
Portfolio Manager | Matthew B. Brown, Seth Kadushin |
Transfer Agent | The Bank of New York Mellon Corporation |
Fiscal Year End | 31-Oct |
Exchange | NYSE Arca, Inc. |
Number of Constituents | 107 |
Market Maker | Virtu Financial |
Total Expense | 0.79 |
Management Fee | 0.79 |
Country Name | USA |
Returns Y T D | 15.91 |
Name | Virtus LifeSci Biotech Clinical Trials ETF |
Currency Code | USD |
Open Figi | BBG007QVCGG1 |
In Threey Volatility | 35.2 |
1y Volatility | 40.74 |
200 Day M A | 23.1401 |
50 Day M A | 27.7732 |
Code | BBC |
Updated At | 27th of March 2024 |
Currency Name | US Dollar |
Virtus LifeSci Biotech [BBC] is traded in USA and was established 2014-12-16. The fund is classified under Health category within Virtus family. The entity is thematically classified as Sector ETFs. Virtus LifeSci Biotech currently have 18.12 M in assets under management (AUM). , while the total return for the last 3 years was -17.4%.
Check Virtus LifeSci Probability Of Bankruptcy
Geographic Allocation (%)
Sector Allocation
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Virtus Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Virtus Etf, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as Virtus LifeSci Biotech Etf, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.
Top Virtus LifeSci Biotech Etf Constituents
ALLK | Allakos | Stock | Health Care |
QURE | Uniqure NV | Stock | Health Care |
VSTM | Verastem | Stock | Health Care |
CLDX | Celldex Therapeutics | Stock | Health Care |
XNCR | Xencor Inc | Stock | Health Care |
ARWR | Arrowhead Pharmaceuticals | Stock | Health Care |
ESPR | Esperion Therapeutics | Stock | Health Care |
Virtus LifeSci Target Price Odds Analysis
What are Virtus LifeSci's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Virtus LifeSci jumping above the current price in 90 days from now is about 18.96%. The Virtus LifeSci Biotech probability density function shows the probability of Virtus LifeSci etf to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the etf has a beta coefficient of 2.194 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Virtus LifeSci will likely underperform. Additionally, virtus LifeSci Biotech has an alpha of 0.1079, implying that it can generate a 0.11 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Virtus LifeSci to move above the current price in 90 days from now is about 18.96 (This Virtus LifeSci Biotech probability density function shows the probability of Virtus Etf to fall within a particular range of prices over 90 days) .
Virtus LifeSci Biotech Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Virtus LifeSci market risk premium is the additional return an investor will receive from holding Virtus LifeSci long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Virtus LifeSci. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Virtus LifeSci's alpha and beta are two of the key measurements used to evaluate Virtus LifeSci's performance over the market, the standard measures of volatility play an important role as well.
Risk Adjusted Performance | 0.1038 | |||
Jensen Alpha | 0.1079 | |||
Total Risk Alpha | (0.12) | |||
Sortino Ratio | 0.128 |
Virtus LifeSci Against Markets
Picking the right benchmark for Virtus LifeSci etf is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Virtus LifeSci etf price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Virtus LifeSci is critical whether you are bullish or bearish towards Virtus LifeSci Biotech at a given time. Please also check how Virtus LifeSci's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Virtus LifeSci without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
All Next | Launch Module |
How to buy Virtus Etf?
Before investing in Virtus LifeSci, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Virtus LifeSci. To buy Virtus LifeSci etf, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Virtus LifeSci. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Virtus LifeSci etf. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Virtus LifeSci Biotech etf in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Virtus LifeSci Biotech etf, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the etf
It's important to note that investing in stocks, such as Virtus LifeSci Biotech, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in etf prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Virtus Etf please use our How to Invest in Virtus LifeSci guide.
Already Invested in Virtus LifeSci Biotech?
The danger of trading Virtus LifeSci Biotech is mainly related to its market volatility and ETF specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Virtus LifeSci is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Virtus LifeSci. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Virtus LifeSci Biotech is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Virtus LifeSci Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Virtus Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Virtus Lifesci Biotech Etf. Highlighted below are key reports to facilitate an investment decision about Virtus Lifesci Biotech Etf: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Virtus LifeSci Biotech. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Virtus LifeSci Biotech information on this page should be used as a complementary analysis to other Virtus LifeSci's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Virtus Etf analysis
When running Virtus LifeSci's price analysis, check to measure Virtus LifeSci's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virtus LifeSci is operating at the current time. Most of Virtus LifeSci's value examination focuses on studying past and present price action to predict the probability of Virtus LifeSci's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virtus LifeSci's price. Additionally, you may evaluate how the addition of Virtus LifeSci to your portfolios can decrease your overall portfolio volatility.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.